Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
WDRGYNZKCMSBDA
|
6.3 | IC50 | 2 | — | |
WIEYJZQXPPXUBY
|
6.3 | IC50 | 2 | — | |
WJBMBTUELASBPU
|
6.3 | IC50 | 2 | — | |
WJJUUNODNYDDEH
|
6.3 | IC50 | 2 | — | |
WLOAIMYFTDHJQN
|
6.3 | IC50 | 2 | — | |
WNBYKLUDVIDFHT
|
6.3 | IC50 | 2 | — | |
WPDXHHXFEPIYSM
|
6.3 | IC50 | 2 | — | |
WQWQUQYMMGXECU
|
6.3 | IC50 | 2 | — | |
WSYAZSOYXLAXAQ
|
6.3 | IC50 | 2 | — | |
WXQJDZCMCHUQBT
|
6.3 | IC50 | 2 | — | |
XDDWFSFOACYPBH
|
6.3 | IC50 | 2 | — | |
XDDWFSFOACYPBH
|
6.3 | IC50 | 2 | — | |
XFNMBSDKHHKSDX
|
6.3 | IC50 | 2 | — | |
XPXNGSKMAANGBP
|
6.3 | IC50 | 2 | — | |
XTDKNYGSWVQNEY
|
6.3 | IC50 | 2 | — | |
XUKNIQVVOZVURK
|
6.3 | IC50 | 2 | — | |
XWVMHVPAGBVWEZ
|
6.3 | IC50 | 2 | — | |
XZCGCWZYIDUOOK
|
6.3 | IC50 | 2 | — | |
YCEJJWWUCHXBOX
|
6.3 | IC50 | 2 | — | |
YLOPNMUGVBWWMV
|
6.3 | IC50 | 2 | — | |
YOEIEWUWUPYITH
|
6.3 | IC50 | 2 | — | |
YPXVZIHPUYHGGE
|
6.3 | IC50 | 2 | — | |
YQWYWDNGKTUEBC
|
6.3 | IC50 | 2 | — | |
YRASKUWOCCDYBE
|
6.3 | IC50 | 2 | — | |
YTIMTHBYEMVBGK
|
6.3 | IC50 | 2 | — | |
YTIMTHBYEMVBGK
|
6.3 | IC50 | 2 | — | |
YUQSCBROVQGUJV
|
6.3 | IC50 | 2 | — | |
YWJQFGIZBQGEGI
|
6.3 | IC50 | 2 | — | |
YYLNOBYRASXXRS
|
6.3 | IC50 | 2 | — | |
YZHPMWRDGCTIGX
|
6.3 | IC50 | 2 | — | |
YZXPNDIFQBNTSO
|
6.3 | IC50 | 2 | — | |
ZALUDWYRJLUVEN
|
6.3 | IC50 | 2 | — | |
ZDSATLCBNDOIBB
|
6.3 | IC50 | 2 | — | |
ZHLNIWMYZLNIEG
|
6.3 | IC50 | 2 | — | |
ZJCNEKFWJHVMDW
|
6.3 | IC50 | 2 | — | |
ZJXSGFKUKZTHTC
|
6.3 | IC50 | 2 | — | |
ZPUWOMDAGPEJAX
|
6.3 | IC50 | 2 | — | |
ZQWMZNLGINPQKE
|
6.3 | IC50 | 2 | — | |
ZWBGOXLJLHWSLZ
|
6.3 | IC50 | 2 | — | |
ZYUPXRAUFYTHFM
|
6.3 | IC50 | 2 | — | |
AZQRUTJNKDXVPR
|
6.2 | IC50 | 2 | — | |
BBSNLVGUSKQSBU
|
6.2 | IC50 | 2 | — | |
BXKBUWYXXKDGHW
|
6.2 | IC50 | 6 | — | |
CMPFTOKTVXYPFY
|
6.2 | IC50 | 4 | — | |
JWRGIVHRSKLDID
|
6.2 | IC50 | 2 | — | |
PGPHHJBZEGSUNE
|
6.2 | IC50 | 21 | — | |
QIYPQJHMRBXGMO
|
6.2 | IC50 | 3 | Yes | |
DAGAGBZRNRKMGJ
|
6.2 | IC50 | 2 | — | |
VMHDKSJEGBWITL
|
6.2 | IC50 | 2 | — | |
WDPQQGKAKPLXAJ
|
6.2 | IC50 | 4 | — |